Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Bojke
Observed names:
BOJKE, LAURA,
Bojke L,
Bojke, Laura,
L Bojke,
L. Bojke,
LAURA BOJKE,
Laura, Bojke
show all 7
Institution:
University of York
Observed institutions:
National Health Service,
Leeds General Infirmary,
University of Leeds,
Bangor University,
MRC Biostatistics Unit,
St Mary's Hospital,
University of York,
Teesside University,
University of Sheffield
show all 9
ORCID:
0000-0001-7921-9109
Observed ORCID:
0000-0001-7921-9109
OpenAlex ID:
A5046482252
Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment
2006
·
Zo?? Philips
, Laura Bojke
, et al.
·
PharmacoEconomics
·
502
Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model
2006
·
P Whiting
, M Westwood
, et al.
·
Health Technology Assessment
·
201
Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods
2009
·
Laura Bojke
, Karl Claxton
, et al.
·
Value in Health
·
186
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
2006
·
C Main
, L Bojke
, et al.
·
Health Technology Assessment
·
156
PDF
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
2011
·
M Rodgers
, D Epstein
, et al.
·
Health Technology Assessment
·
137
PDF
Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods
2016
·
Christopher Jackson
, John Stevens
, et al.
·
Medical Decision Making
·
127
PDF
The Internet for weight control in an obese sample: results of a randomised controlled trial
2007
·
Áine McConnon
, Sara FL Kirk
, et al.
·
BMC Health Services Research
·
124
PDF
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
2012
·
K Claxton
, S Palmer
, et al.
·
Health Technology Assessment
·
119
PDF
The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease – a UK collaborative study. The REFLUX trial
2008
·
A Grant
, S Wileman
, et al.
·
Health Technology Assessment
·
112
PDF
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study
2021
·
Laura Bojke
, Marta Soares
, et al.
·
Health Technology Assessment
·
102
PDF
A Framework for Addressing Structural Uncertainty in Decision Models
2011
·
Christopher H. Jackson
, Laura Bojke
, et al.
·
Medical Decision Making
·
97
Designing and Undertaking a Health Economics Study of Digital Health Interventions
2016
·
Paul McNamee
, Elizabeth Murray
, et al.
·
American Journal of Preventive Medicine
·
82
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses
2007
·
T Colbourn
, C Asseburg
, et al.
·
Health Technology Assessment
·
82
PDF
Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)
2013
·
AM Grant
, C Boachie
, et al.
·
Health Technology Assessment
·
77
PDF
Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study
2009
·
D. Epstein
, L. Bojke
, et al.
·
BMJ
·
69
PDF
Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses
2007
·
Tim E Colbourn
, Christian Asseburg
, et al.
·
BMJ
·
67
PDF
A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage Decisions
2016
·
Karl Claxton
, Stephen Palmer
, et al.
·
Value in Health
·
60
PDF
Methods to elicit experts’ beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration
2011
·
Marta O. Soares
, Laura Bojke
, et al.
·
Statistics in Medicine
·
60
Experiences of Structured Elicitation for Model-Based Cost-Effectiveness Analyses
2018
·
Marta O. Soares
, Linda Sharples
, et al.
·
Value in Health
·
55
PDF
Eliciting Distributions to Populate Decision Analytic Models
2010
·
Laura Bojke
, Karl Claxton
, et al.
·
Value in Health
·
52
Cost-effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of gastro-oesophageal reflux disease based on long-term follow-up of the REFLUX trial
2013
·
R Faria
, L Bojke
, et al.
·
British journal of surgery
·
49
Digital interventions in mental health: evidence syntheses and economic modelling
2022
·
Lina Gega
, Dina Jankovic
, et al.
·
Health Technology Assessment
·
48
PDF
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
2017
·
Mark Corbett
, Fadi Chehadah
, et al.
·
Health Technology Assessment
·
45
PDF
Golimumab for the Treatment of Psoriatic Arthritis
2012
·
Huiqin Yang
, Dawn Craig
, et al.
·
PharmacoEconomics
·
43
Reference Case Methods for Expert Elicitation in Health Care Decision Making
2021
·
Laura Bojke
, Marta O. Soares
, et al.
·
Medical Decision Making
·
42
Show more works
View as search
Works count:
212
Citation count:
3,856
H-index:
33
I10-index:
68
Year
Topic
Type
